78 F
New York
Saturday, July 2, 2022

Conformis [NASDAQ: CFMS] Entered A Non-Exclusive agreement with SITES Medical

Must read

Conformis Inc [NASDAQ: CFMS] revealed that the company inked a development and supply contract with sites medical. Both of the companies will work together to embed OsteoSync TI technology of SITES Medical into future cementless knee replacement products by Conformis.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The Osteosync Ti technology is a highly permeable titanium bone ingrowth material. Moreover, Its design is to meet the needs of health stakeholders. Greg Stalcup  CEO and president of SITES Medical states “ We are glad to be collaborating with Conformis. Furthermore, We look forward to combining our respective technologies to deliver cost-effective and high-performance products to the market.”

John SLamin SVP Confromis said, “ We’re glad to sign this contract. Additionally we anticipate working with SITES Medical and applying their technology to our future cementless knee replacement product”.

More articles

Latest article



Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam